Mannatech Reports Q1 2025 Financials: Net Sales Down 9.6%, Net Loss of $1.5 Million, EPS at -$0.80

Reuters
05-14
Mannatech Reports Q1 2025 Financials: Net Sales Down 9.6%, Net Loss of $1.5 Million, EPS at -$0.80

Mannatech, Incorporated $(MTEX)$, a global health and wellness company, announced its financial results for the first quarter of 2025. The company reported net sales of $26.6 million for the quarter ending March 31, 2025, reflecting a 9.6% decrease compared to $29.4 million in the same period in 2024. This decline was attributed to slowing demand in Asia due to weakened economic conditions. On a constant dollar basis, net sales decreased by $1.6 million, or 5.4%, while unfavorable foreign exchange led to a $1.2 million decrease in GAAP net sales. Mannatech reported a net loss of $1.5 million for the first quarter of 2025, contrasting with a net income of $1.2 million for the same period in the previous year. The company's cash and cash equivalents decreased by 18.2%, or $2.1 million, to $9.3 million as of March 31, 2025, from $11.4 million as of December 31, 2024. The number of new and continuing independent associate and preferred customer positions in Mannatech's network was approximately 129,000 as of March 31, 2025, compared to 143,000 in the same period of 2024, marking a 13.9% decrease in recruitment. Management noted that changes in current trade policies could impact the company's cost structure and profitability.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mannatech Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001056358-25-000049), on May 13, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10